New drug LY03020: does food change how it works?
NCT ID NCT07292233
First seen Jan 09, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study looks at whether eating food changes how the body absorbs a new medicine called LY03020, which is being developed for schizophrenia and Alzheimer's-related psychosis. Sixteen healthy adults will take the drug once with food and once without, and researchers will measure drug levels and safety. The goal is to understand the best way to take the medicine, not to treat any disease directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing AnDing Hospital Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.